Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
1515.HK
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.20
-44%
0.09
vs 0.17
Q4.20
+2%
0.19
vs 0.19
Q2.21
+102%
0.19
vs 0.09
Q4.21
+11%
0.21
vs 0.19
Q2.22
+20%
0.23
vs 0.19
Q4.22
-91%
0.02
vs 0.21
Q2.23
+49%
0.34
vs 0.23
Q4.23
N/A
-0.12
vs 0.02
Q2.24
+8%
0.37
vs 0.34
Q4.24
+191%
0.11
vs -0.12
Sales Growth
YoY
Current
Estimates
Q2.20
-6%
907.4M vs 964.9M
Q4.20
+60%
1.8B vs 1.2B
Q2.21
+95%
1.8B vs 907.4M
Q4.21
+45%
2.7B vs 1.8B
Q2.22
+81%
3.2B vs 1.8B
Q4.22
+76%
4.7B vs 2.7B
Q2.23
+60%
5.1B vs 3.2B
Q4.23
+6%
5B vs 4.7B
Q2.24
-3%
5B vs 5.1B
Q4.24
-2%
4.9B vs 5B
Return on Equity
QoQ
Q2.21
+3%
0.03
vs 0.03
Q4.21
+3%
0.03
vs 0.03
Q2.22
+4%
0.04
vs 0.03
Q4.22
+0%
0
vs 0.04
Q2.23
+7%
0.07
vs 0
Q4.23
-2%
-0.02
vs 0.07
Q2.24
+7%
0.07
vs -0.02
Q4.24
+2%
0.02
vs 0.07
Institutionnal Ownership
Quote Panel
Key Metrics
Relative Strength
1515.HK
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
China Resources Medical Holdings Company Limited, an investment holding company, provides general healthcare, and hospital management and consulting services in the People's Republic of China. The ocmapny operates in three segments: Self-Owned Hospitals, Invest-Operate-Transfer/Operate-Transfer Hospitals, and Others. It also offers group purchasing organization and other hospital-derived services. In addition, the company manages and operates third-party hospitals and clinics under the invest-operate-transfer model. Further, it sells pharmaceuticals, medical devices, and medical consumables and equipment. The company was formerly known as China Resources Phoenix Healthcare Holdings Company Limited and changed its name to China Resources Medical Holdings Company Limited in October 2018. China Resources Medical Holdings Company Limited was founded in 2007 and is headquartered in Beijing, the People's Republic of China.
HKSE
-0.07Â ( -1.67%)
Relative Strenght
Volume Buzz
-27%
Earning Acce
No
Dist 52w H.
18%Forecast
126%2025-Revenue
406%2025-EPS
217%2025-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 1515.HK compares to sector?
1515.HK
8x